PRER14A

Company

Emmaus Life Sciences, Inc.

Filed

November 2, 2018

Period of Report

November 26, 2018

Accession Number

0001615774-18-011992

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →